Certified by Founder
Lodge
Xenocor
start up
United States
- Salt Lake City, Utah
- 19/04/2023
- Series A
- $10,000,000
Xenocor is actively solving challenges in minimally invasive surgery by bringing the Saberscope single-use, fog-free, articulating laparoscopic platform to market.
Xenocor is a privately held corporation, based in Salt Lake City, UT. Learn more at: www.saberscope.com/resources
- Industry Medical Equipment Manufacturing
- Website https://xenocor.com/
- LinkedIn https://www.linkedin.com/company/xenocor/
Related People
Charles DeCoster IVFounder
United States -
Washington, Utah
Life Sciences senior leader specializing in Investor Relations, Strategy, Business Development/M&A, Upstream Marketing and Portfolio Management
Lua AI (YC F25) | $5,800,000 | (Apr 17, 2026)
Joyful Health | $17,000,000 | (Apr 17, 2026)
Worki.ai | $2,750,000 | (Apr 17, 2026)
Balerion AI | $6,000,000 | (Apr 17, 2026)
Beeline Medicines | $300,000,000 | (Apr 17, 2026)
Resolv | $1,000,000 | (Apr 17, 2026)
Solidroad | $25,000,000 | (Apr 17, 2026)
Ralio | $2,500,000 | (Apr 16, 2026)
Parasail | $32,000,000 | (Apr 16, 2026)
Modern Relay | $3,000,000 | (Apr 16, 2026)
Gitar | $9,000,000 | (Apr 16, 2026)
Terremoto Biosciences | $108,000,000 | (Apr 16, 2026)